| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-52671-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB200-206-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-08985-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-34515-0.1mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-34563-0.1mg | |||
![Immunocytochemistry/Immunofluorescence: Daxx Antibody (DAXX-01) [NB500-491] - 1B - HeLa cells were co-transfected with pCDNA3-MycDaxx and pCDNA3-ASK1HA, which led to translocation of Daxx from nucleus to cytoplasm](http://images.novusbio.com/fullsize/Daxx-Antibody-DAXX-01-Immunocytochemistry-Immunofluorescence-NB500-491-img0002.jpg "Immunocytochemistry/Immunofluorescence: Daxx Antibody (DAXX-01) [NB500-491] - 1B - HeLa cells were co-transfected with pCDNA3-MycDaxx and pCDNA3-ASK1HA, which led to translocation of Daxx from nucleus to cytoplasm")
![Immunocytochemistry/Immunofluorescence: Daxx Antibody (DAXX-01) [NB500-491] - Fig. 1. Immunofluorescence staining of Daxx in transfected HeLa human cervix carcinoma cell line. Myc Daxx (green) was stained with anti-human Daxx (DAXX-01), nuclei were stained with DAPI (blue). 1A - nuclear localization of Daxx in HeLa cells transfected with pCDNA3-MycDaxx.](http://images.novusbio.com/fullsize/Daxx-Antibody-DAXX-01-Immunocytochemistry-Immunofluorescence-NB500-491-img0001.jpg)
![Western Blot: NCOA6 Antibody (2D7) [H00023054-M01] - NCOA6 monoclonal antibody (M01), clone 2D7 Analysis of NCOA6 expression in Hela S3 NE.](http://images.novusbio.com/fullsize/NCOA6-Antibody-2D7-Western-Blot-H00023054-M01-img0005.jpg "Western Blot: NCOA6 Antibody (2D7) [H00023054-M01] - NCOA6 monoclonal antibody (M01), clone 2D7 Analysis of NCOA6 expression in Hela S3 NE.")
![Immunocytochemistry/Immunofluorescence: NCOA6 Antibody (2D7) [H00023054-M01] - Analysis of monoclonal antibody to NCOA6 on HeLa cell. Antibody concentration 10 ug/ml.](http://images.novusbio.com/fullsize/NCOA6-Antibody-2D7-Immunocytochemistry-Immunofluorescence-H00023054-M01-img0004.jpg)
![Western Blot: SGLT2/SLC5A2 Antibody (3G8) [H00006524-M01] - Analysis of SLC5A2 expression in transfected 293T cell line by SLC5A2 monoclonal antibody (M01), clone 3G8.Lane 1: SLC5A2 transfected lysate(72.9 KDa).Lane 2: Non-transfected lysate.](http://images.novusbio.com/fullsize/SGLT2-SLC5A2-Antibody-3G8-Western-Blot-H00006524-M01-img0003.jpg "Western Blot: SGLT2/SLC5A2 Antibody (3G8) [H00006524-M01] - Analysis of SLC5A2 expression in transfected 293T cell line by SLC5A2 monoclonal antibody (M01), clone 3G8.Lane 1: SLC5A2 transfected lysate(72.9 KDa).Lane 2: Non-transfected lysate.")
![Sandwich ELISA: SGLT2/SLC5A2 Antibody (3G8) [H00006524-M01] - Detection limit for recombinant GST tagged SLC5A2 is 0.03 ng/ml as a capture antibody.](http://images.novusbio.com/fullsize/SGLT2-SLC5A2-Antibody-3G8-Sandwich-ELISA-H00006524-M01-img0002.jpg)
![In vitro assay: Recombinant Human SOD1/Cu-Zn SOD Active, Monomer Protein [NBP3-14782] - Thioflavin T assay of SOD1 pre-formed fibrils (PFFs) combined with SOD1 monomers (NBP3-14782). Pre-formed fibrils seed the aggregation of monomers, leading to an increase in Thioflavin T fluorescence](http://images.novusbio.com/fullsize/Recombinant-Human-SOD1-Cu-Zn-SOD-Active--Monomer-Protein-In-vitro-assay-NBP3-14782-img0001.jpg "In vitro assay: Recombinant Human SOD1/Cu-Zn SOD Active, Monomer Protein [NBP3-14782] - Thioflavin T assay of SOD1 pre-formed fibrils (PFFs) combined with SOD1 monomers (NBP3-14782). Pre-formed fibrils seed the aggregation of monomers, leading to an increase in Thioflavin T fluorescence")
![SDS-Page: Recombinant Human SOD1/Cu-Zn SOD Active, Monomer Protein [NBP3-14782] - SDS-PAGE of human SOD1 monomer protein (NBP3-14782). Load: 2 ug](http://images.novusbio.com/fullsize/Recombinant Human SOD1-Cu-Zn SOD Active- Monomer Protein-SDS-Page-NBP3-14782-img0002.jpg)
![Immunohistochemistry: Bax Antibody (6A7) - Chimeric [NBP3-08985] - Formalin fixed human lung cancer slices were were stained with a NBP3-08985 at 3 ug/ml.](http://images.novusbio.com/fullsize/Bax-Antibody-6A7-Chimeric-Immunohistochemistry-NBP3-08985-img0001.jpg "Immunohistochemistry: Bax Antibody (6A7) - Chimeric [NBP3-08985] - Formalin fixed human lung cancer slices were were stained with a NBP3-08985 at 3 ug/ml.")
![Western Blot: Profilin 1 [p Ser138] Antibody [NBP3-23342] - Western blot of Jurkat stimulated with calyculin A (100 nM) for 30 min (lanes 1-6). The blots were probed with anti-Profilin (a.a. 132-140) (lanes 1-3) or anti-Profilin (Ser-138) phospho-specific (lanes 4-6). Both antibodies were used in the absence (lanes 1 & 4) or presence of unphosphorylated Profilin (Ser-138) (lanes 2 & 5) or phospho-Profilin (Ser-138) (lanes 3 & 6) blocking peptides.](http://images.novusbio.com/fullsize/nbp3-23342_rabbit-profilin-1-p-ser138-pab-18920231735520.jpg "Western Blot: Profilin 1 [p Ser138] Antibody [NBP3-23342] - Western blot of Jurkat stimulated with calyculin A (100 nM) for 30 min (lanes 1-6). The blots were probed with anti-Profilin (a.a. 132-140) (lanes 1-3) or anti-Profilin (Ser-138) phospho-specific (lanes 4-6). Both antibodies were used in the absence (lanes 1 & 4) or presence of unphosphorylated Profilin (Ser-138) (lanes 2 & 5) or phospho-Profilin (Ser-138) (lanes 3 & 6) blocking peptides.")
![Western Blot: Profilin 1 [p Ser138] Antibody [NBP3-23342] - Western blot of human recombinant Profilin-1 phosphorylated in vitro with PKC alpha kinase then untreated (-) or treated with lambdaphosphatase (+). The blots were probed with anti-Profilin (a.a. 126-137) (left panel) or anti-Profilin (Ser-138) phospho-specific (right panel) antibodies at 1:1000.](http://images.novusbio.com/fullsize/nbp3-23342_rabbit-profilin-1-p-ser138-pab-199202312523637.jpg)
![Western Blot: c-Abl [p Tyr412] Antibody [NBP3-23318] - Western blot analysis of K-562 cells treated with pervanadate (1 mM) for 30 minutes (lanes 1, 3, & 5). Some lanes were treated with alkaline phosphatase to remove phosphorylation on c-Abl (lanes 2, 4, & 6), then the blots were probed with anti-c-Abl (lanes 1 & 2), anti-c-Abl (Tyr-412) (NBP3-23318; lanes 3 & 4), or anti-c-Abl (Tyr-245) (NBP3-23313; lanes 5 & 6).](http://images.novusbio.com/fullsize/nbp3-23318_rabbit-c-abl-p-tyr412-pab-19920231915414.jpg "Western Blot: c-Abl [p Tyr412] Antibody [NBP3-23318] - Western blot analysis of K-562 cells treated with pervanadate (1 mM) for 30 minutes (lanes 1, 3, & 5). Some lanes were treated with alkaline phosphatase to remove phosphorylation on c-Abl (lanes 2, 4, & 6), then the blots were probed with anti-c-Abl (lanes 1 & 2), anti-c-Abl (Tyr-412) (NBP3-23318; lanes 3 & 4), or anti-c-Abl (Tyr-245) (NBP3-23313; lanes 5 & 6).")
![Western Blot: c-Abl Antibody (M209) [NBP3-23312] - Western blot analysis of K-562 cells treated with pervanadate (1 mM) for 30 minutes (lanes 1, 3, & 5). Some lanes were treated with alkaline phosphatase to remove phosphorylation on c-Abl (lanes 2, 4, & 6), then the blots were probed with anti-c-Abl (lanes 1 & 2), anti-c-Abl (Tyr-412) (NBP3-23318; lanes 3 & 4), or anti-c-Abl (Tyr-245) (NBP3-23313; lanes 5 & 6).](http://images.novusbio.com/fullsize/nbp3-23312_mouse-c-abl-mab-m209-9820231138390.jpg "Western Blot: c-Abl Antibody (M209) [NBP3-23312] - Western blot analysis of K-562 cells treated with pervanadate (1 mM) for 30 minutes (lanes 1, 3, & 5). Some lanes were treated with alkaline phosphatase to remove phosphorylation on c-Abl (lanes 2, 4, & 6), then the blots were probed with anti-c-Abl (lanes 1 & 2), anti-c-Abl (Tyr-412) (NBP3-23318; lanes 3 & 4), or anti-c-Abl (Tyr-245) (NBP3-23313; lanes 5 & 6).")
![Western Blot: c-Abl Antibody (M209) [NBP3-23312] - Western blot analysis of K-562 cells treated with pervanadate (1 mM) for 30 minutes (lanes 1, 3, & 5). Some lanes were treated with alkaline phosphatase to remove phosphorylation on c-Abl (lanes 2, 4, & 6), then the blots were probed with anti-c-Abl (lanes 1 & 2), anti-c-Abl (Tyr-412) (NBP3-23318; lanes 3 & 4), or anti-c-Abl (Tyr-245) (NBP3-23313; lanes 5 & 6).](http://images.novusbio.com/fullsize/nbp3-23312_mouse-c-abl-mab-m209-19920231915412.jpg)
![Immunohistochemistry-Paraffin: Bcl-2 Antibody (100/D5+124) - IHC-Prediluted [NBP2-44782] - Formalin-fixed, paraffin-embedded human non-Hodgkin's lymphoma stained with Bcl-2 MAb (100/D5 + 124). Note nuclear membrane & cytoplasmic staining.](http://images.novusbio.com/fullsize/Bcl-2-Antibody-100-D5+124-IHC-Prediluted-Immunohistochemistry-Paraffin-NBP2-44782-img0001.jpg "Immunohistochemistry-Paraffin: Bcl-2 Antibody (100/D5+124) - IHC-Prediluted [NBP2-44782] - Formalin-fixed, paraffin-embedded human non-Hodgkin's lymphoma stained with Bcl-2 MAb (100/D5 + 124). Note nuclear membrane & cytoplasmic staining.")
![Immunohistochemistry-Paraffin: p53 Antibody (BP53-12 + DO-7) - IHC-Prediluted [NBP2-44980] - Formalin-fixed, paraffin-embedded human cervical carcinoma stained with P53 Monoclonal antibody (BP53-12 +DO-7)](http://images.novusbio.com/fullsize/p53-Antibody-BP53-12-+-DO-7-IHC-Prediluted-Immunohistochemistry-Paraffin-NBP2-44980-img0001.jpg "Immunohistochemistry-Paraffin: p53 Antibody (BP53-12 + DO-7) - IHC-Prediluted [NBP2-44980] - Formalin-fixed, paraffin-embedded human cervical carcinoma stained with P53 Monoclonal antibody (BP53-12 +DO-7)")